{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:45:29Z","timestamp":1790696729531,"version":"4.1.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1210\/jc.2012-3200","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T13:48:19Z","timestamp":1365169699000},"page":"1307-1318","source":"Crossref","is-referenced-by-count":77,"title":["Approach to the Cushing's Disease Patient With Persistent\/Recurrent Hypercortisolism After Pituitary Surgery"],"prefix":"10.1210","volume":"98","author":[{"given":"Xavier","family":"Bertagna","sequence":"first","affiliation":[{"name":"Service des Maladies Endocriniennes et M\u00e9taboliques, Centre de R\u00e9f\u00e9rence des Maladies Rares de la Surr\u00e9nale, H\u00f4pital Cochin, Facult\u00e9 Paris Descartes, Universit\u00e9 Paris 5, Paris 75014, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Guignat","sequence":"additional","affiliation":[{"name":"Service des Maladies Endocriniennes et M\u00e9taboliques, Centre de R\u00e9f\u00e9rence des Maladies Rares de la Surr\u00e9nale, H\u00f4pital Cochin, Facult\u00e9 Paris Descartes, Universit\u00e9 Paris 5, Paris 75014, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113284950800_B1","first-page":"533","article-title":"Cushing's disease","volume-title":"The Pituitary","author":"Bertagna","year":"2001","edition":"3rd ed"},{"key":"key\n\t\t\t\t2019041113284950800_B2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113284950800_B3","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ncpendmet0947","article-title":"Management of recurrent and refractory Cushing disease","volume":"4","author":"Aghi","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113284950800_B6","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","article-title":"Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery","volume":"97","author":"Dickerman","year":"2002","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t2019041113284950800_B8","first-page":"3973","article-title":"Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins","volume":"6","author":"Clayton","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113284950800_B9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2265.2001.01324.x","article-title":"Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease","volume":"55","author":"Losa","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113284950800_B10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/EJE-11-0424","article-title":"Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery","volume":"165","author":"Bou Khalil","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1227\/01.NEU.0000215945.26764.92","article-title":"Surgical treatment of recurrent Cushing's disease","volume":"58","author":"Hofmann","year":"2006","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t2019041113284950800_B12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3171\/jns.2005.102.6.1004","article-title":"Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma","volume":"102","author":"Benveniste","year":"2005","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t2019041113284950800_B13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3171\/jns.1994.80.1.0037","article-title":"Early repeat surgery for persistent Cushing's disease","volume":"80","author":"Ram","year":"1994","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t2019041113284950800_B14","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2004-2436","article-title":"Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease","volume":"90","author":"Locatelli","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B15","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2008-2772","article-title":"Long-term results of stereotactic radiosurgery in secretory pituitary adenomas","volume":"94","author":"Castinetti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113284950800_B17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MED.0b013e32833ab069","article-title":"Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review","volume":"17","author":"Starke","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key\n\t\t\t\t2019041113284950800_B18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1677\/ERC-08-0231","article-title":"Radiation-induced hypopituitarism","volume":"16","author":"Fernandez","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019041113284950800_B19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B20","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMc1204078","article-title":"Pasireotide in Cushing's disease","volume":"366","author":"Lib\u00e9","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113284950800_B21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4158\/EP10031.OR","article-title":"Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy","volume":"16","author":"Lila","year":"2010","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113284950800_B24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113284950800_B27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0960-0760(94)90267-4","article-title":"Therapy of Cushing's syndrome with steroid biosynthesis inhibitors","volume":"49","author":"Engelhardt","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t2019041113284950800_B28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.2.6081.215","article-title":"Metyrapone in long-term management of Cushing's disease","volume":"2","author":"Jeffcoate","year":"1977","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041113284950800_B29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113284950800_B30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.1991.tb03547.x","article-title":"Ketoconazole treatment in Cushing's syndrome: experience in 34 patients","volume":"35","author":"Sonino","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113284950800_B31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B32","first-page":"1325","article-title":"Long-term treatment of Cushing's disease using ketoconazole. Possibility of therapeutic escape [in French]","volume":"18","author":"Diop","year":"1989","journal-title":"Presse Med"},{"key":"key\n\t\t\t\t2019041113284950800_B33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jcem-70-5-1426","article-title":"Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects","volume":"70","author":"Schulte","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B34","article-title":"Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11\u03b2-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study","author":"Bertagna"},{"key":"key\n\t\t\t\t2019041113284950800_B35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"16","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","article-title":"Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience","volume":"68","author":"Chow","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113284950800_B37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","article-title":"Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy","volume":"208","author":"Smith","year":"2009","journal-title":"J Am Coll Surg"},{"key":"key\n\t\t\t\t2019041113284950800_B38","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","article-title":"Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience","volume":"245","author":"Thompson","year":"2007","journal-title":"Ann Surg"},{"issue":"3","key":"key\n\t\t\t\t2019041113284950800_B39","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/foc.2007.23.3.14","article-title":"Nelson syndrome: historical perspectives and current concepts","volume":"23","author":"Hornyak","year":"2007","journal-title":"Neurosurg Focus"},{"key":"key\n\t\t\t\t2019041113284950800_B40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","article-title":"Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/jc.2010-2235","article-title":"Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome","volume":"96","author":"Jornayvaz","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B42","first-page":"3568","article-title":"Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing's syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B44","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jcem-63-3-639","article-title":"Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome","volume":"63","author":"Bertagna","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-92-5-613","article-title":"Sustained remission of Cushing's disease with mitotane and pituitary irradiation","volume":"92","author":"Schteingart","year":"1980","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113284950800_B47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11102-009-0209-8","article-title":"Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease","volume":"13","author":"Vilar","year":"2010","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041113284950800_B48","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenicky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B49","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113284950800_B50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MED.0b013e328305082f","article-title":"Work-up and management of paediatric Cushing's syndrome","volume":"15","author":"Savage","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key\n\t\t\t\t2019041113284950800_B51","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B52","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113284950800_B53","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1210\/jc.2010-0644","article-title":"Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience","volume":"95","author":"Raverot","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113284950800_B54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t2019041113284950800_B55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrendo.2012.54","article-title":"The pituitary tumour epigenome: aberrations and prospects for targeted therapy","volume":"8","author":"Yacqub-Usman","year":"2012","journal-title":"Nat Rev Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/4\/1307\/9044414\/jcem1307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T18:35:31Z","timestamp":1562870131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/4\/1307\/2536639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3200","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}